Technical Analysis for DARE - Dare Bioscience, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Down | Down |
Historical DARE trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 50 DMA | Bearish | 0.00% | |
MACD Bearish Centerline Cross | Bearish | 0.00% | |
Lower Bollinger Band Walk | Weakness | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Below Lower BB | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
50 DMA Support | Bullish | -3.11% | |
Lower Bollinger Band Walk | Weakness | -3.11% | |
Below Lower BB | Weakness | -3.11% | |
Lower Bollinger Band Touch | Weakness | -3.11% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time | |
---|---|---|
50 DMA Support | about 21 hours ago | |
Down 5% | about 22 hours ago | |
Fell Below Previous Day's Low | about 22 hours ago | |
Rose Above Lower Bollinger Band | about 22 hours ago | |
50 DMA Resistance | about 22 hours ago |
Get a Trading Assistant
- Earnings date: 03/29/2021
Dare Bioscience, Inc. Description
Dare Bioscience, Inc., formerly Cerulean Pharma Inc., is a healthcare company. The Company is focused on the development and commercialization of products in women’s reproductive health. Its lead product candidate is Ovaprene, a clinical stage, non-hormonal contraceptive ring. The Company is developing Ovaprene to provide protection over multiple weeks of use and require no intervention at the time of intercourse. Ovaprene has a custom intravaginal ring design, with a permeable mesh in the center of the ring that creates a partial barrier to sperm, and a mechanism to release locally acting spermiostatic agents through the ring. The combination of these two complementary approaches produces attractive contraceptive efficacy outcomes that are consistent with the effective barrier option, the diaphragm, and short-acting hormonal options, such as oral pill, patches and vaginal ring.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Drugs Vagina Diaphragm Reproductive Health Women's Health Hormonal Contraception Medroxyprogesterone Acetate
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 3.85 |
52 Week Low | 0.75 |
Average Volume | 3,382,835 |
200-Day Moving Average | 1.30 |
50-Day Moving Average | 1.90 |
20-Day Moving Average | 2.23 |
10-Day Moving Average | 2.12 |
Average True Range | 0.22 |
ADX | 23.04 |
+DI | 19.08 |
-DI | 31.20 |
Chandelier Exit (Long, 3 ATRs ) | 1.91 |
Chandelier Exit (Short, 3 ATRs ) | 2.40 |
Upper Bollinger Band | 2.57 |
Lower Bollinger Band | 1.89 |
Percent B (%b) | -0.03 |
BandWidth | 30.42 |
MACD Line | -0.01 |
MACD Signal Line | 0.07 |
MACD Histogram | -0.0812 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 2.08 | ||||
Resistance 3 (R3) | 2.08 | 2.02 | 2.05 | ||
Resistance 2 (R2) | 2.02 | 1.96 | 2.02 | 2.03 | |
Resistance 1 (R1) | 1.94 | 1.93 | 1.94 | 1.94 | 2.02 |
Pivot Point | 1.88 | 1.88 | 1.88 | 1.88 | 1.88 |
Support 1 (S1) | 1.80 | 1.82 | 1.80 | 1.80 | 1.72 |
Support 2 (S2) | 1.74 | 1.79 | 1.74 | 1.71 | |
Support 3 (S3) | 1.66 | 1.74 | 1.70 | ||
Support 4 (S4) | 1.66 |